Long-chain polyunsaturated fatty acids (PUFAs) might regulate T-cell activation and lineage commitment. Here, we measured the effects of omega-3 (n-3), n-6 and n-9 fatty acids on the interaction between dendritic cells (DCs) and naïve T cells. Spleen DCs from BALB/c mice were cultured in vitro with ovalbumin (OVA) with 50 μM fatty acids; α-linolenic acid, arachidonic acid (AA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid or oleic acid and thereafter OVA-specific DO11.10 T cells were added to the cultures. Fatty acids were taken up by the DCs, as shown by gas chromatography analysis. , in co-cultures with arachidonic acid-or DHAprimed DCs relative to control cultures. The proportion of putative Tregs was inversely correlated to T-cell proliferation, indicating a suppressive function of these cells. With arachidonic acid DCs produced higher levels of prostaglandin E 2 while T cells produced lower amounts of IL-10 and IFNγ. In conclusion arachidonic acid and DHA induced up-regulation of activation markers on DCs. However arachidonic acid-and DHA-primed DCs reduced Tcell proliferation and increased the proportion of T cells expressing FoxP3, indicating that these fatty acids can promote induction of regulatory T cells.
Introduction
Lymphoid organs are embedded in fat [1] and fatty acids, especially long-chain polyunsaturated fatty acids (PUFAs) have immunoregulatory functions via several mechanisms. They are incorporated into cell membranes and affect fluidity, formation of lipid rafts and protein configuration and are thereby modulating cell communication [2] but they also affect intracellular signaling. Fatty acids diffuse through the membrane freely, or via transporters, bind to cytoplasmic receptors termed fatty acid binding proteins and translocate to the nucleus, where they affect gene transcription. Lastly, some PUFAs are precursors of lipid mediators [3] , which participate in inflammatory processes and also affect acquired immune cells. For example, prostaglandins are potent inhibitors of T-cell proliferation [4] . The most prominent effect of PUFAs is inhibited T-cell proliferation [5] [6] [7] [8] [9] [10] [11] [12] , particularly that of Th1 cells [13] . In general, the longer chains and the higher degree of unsaturation, the stronger inhibitory effect [10] .
Antigen presenting cells, such as dendritic cells (DCs), initiate and regulate T-cell responses. DCs can have myeloid or lymphoid origin and these subsets differ in phenotype, localization, and function. In mice, simplified, myeloid DCs are CD11b + CD8 -while lymphoid DCs are CD11b -CD8 + DEC-205 + [14] . Both subsets express high levels of CD11c, MHC class II, CD86
and CD40 [15] . The heterogeneity of DCs makes it difficult to assign fixed functions to the subsets [16] , but in general CD11b + DCs present MHC class II-restricted antigens to CD4 + T cells [14] , inducing a proliferative response [17] . On the contrary lymphoid CD8 + DCs induce a limited CD4 + T cell response, associated with apoptosis [18] , as well as Th1 differentiation [19] .
Presentation of antigen to naïve T cells results in activation or tolerance, depending on interaction of MHC molecule-TCR complex interaction, expression of costimulatory molecules, cell adhesion and cytokine milieu. Mature DCs express the glycoprotein CD83, related to the B7 ancestral family [20] . Costimulatory molecules on DCs include CD80 (B7-1) and CD86 (B7-2) that bind to CD28 on T cells, inducing T-cell activation and proliferation. However, CD80 and CD86 can also bind to CTLA-4 (CD152) [21] , which inhibits T cell IL-2 secretion and proliferation [22] . Programmed cell death ligand 1 (PDL-1/CD274) on DCs inhibits T-cell activation and proliferation through interaction with programmed death-1 (PD-1, PDCD1/ CD279) on T cells [23] . PD-1 is involved in regulation of peripheral tolerance and autoimmunity and the PD-1: PDL pathway promotes maturation of naïve T cells into FoxP3 + CD4 + regulatory T cells (Tregs) [24] . Long-chain PUFAs affect cytokine secretion and expression of costimulatory molecules on DCs [25] . In general fish oil and n-3 PUFAs reduce costimulatory molecules and antigen-presentation capacity, measured as subsequent T-cell activation [26] [27] [28] [29] [30] . The effects vary between different fatty acids, also between different n-3 PUFAs [31] , dose and exposure time [5] and maturation stage of the DCs [32] . In this study, the immunoregulatory effects of fatty acids were tested by in vitro culture of murine CD11c + DCs with free fatty acids. We evaluated DC phenotype, ability of fatty acid-primed DCs to activate T cells as well as subsequent T-cell phenotype.
Material and Methods Animals
Male BALB/c mice (Charles River, Sulzfeld, Germany) were 6-8 weeks old when used to collect dendritic cells. Male DO11.10 H-2d [OVA T-cell receptor transgenic] BALB/c mice were the source of OVA-specific naïve T cells. They were bred at the animal facility at the University of Gothenburg under standard conditions. The study was carried out in accordance with recommendations from the Swedish board of agriculture and approved by the regional ethical committee (Göteborgs djurförsöksetiska nämnd, permit number: 365-2011/68-2012). Mice were sacrificed by cervical dislocation.
Dendritic cell: T cell co-culture
The experimental design is shown in S1 ) were cultured in 96-well plates (Zellkultur Testplatte 96U, TPP) in Iscove's modified Dulbecco's medium (Sigma-Aldrich Co., St Louis, MO) supplemented with 10% fetal bovine serum, 1% β-mercaptoethanol (4 mM solution), 1% L-glutamine (200 mM solution, Sigma-Aldrich) and 0.1% gentamicin (50 mg/ml solution, GIBCO/Invitrogen, Eugene, OR). Fatty acids were dissolved in ethanol and added to DC cultures in a final concentration of 50 μM, a physiological concentration in plasma [33, 34] , within a range of concentrations that have been used in previous in vitro experiments [5, 8, 12] . The final ethanol concentration in the cell cultures was max 1%, when ethanol alone was used as control. The following fatty acids were used; 18:1 n-9 oleic acid (OA), 18:2 n-6 linoleic acid (LA), 18:3 n-3 α-linolenic acid (ALA), 20:4 n-6 arachidonic acid (AA), 20:5 n-3 eicosapentaenoic acid (EPA) and 22:6 n-3 DHA were used (all from Sigma-Aldrich with purity !98%). Purity of stock solutions was tested by gas chromatography-mass spectrometry analysis, and found to be > 90% (S2 Fig). Stock solutions of fatty acids as well as cell culture medium were tested for presence of staphylococcal enterotoxin with the SET-RPLA kit (Oxoid Ltd, Basingstoke, UK) and found to be endotoxin free. OVA (grade III, Sigma-Aldrich) was added to a final concentration of 0.5 μg/μl in cell cultures later used for T-cell analysis. For blocking experiments purified antimouse CD83 (HB15, clone Michel-17) or PD-1 (CD279) (clone RMP1-14) antibodies were used in a final concentration of 10 μg/ml (both from eBioscience Inc., San Diego, CA). After 3 days the DCs were either harvested for FACS analysis of phenotype or further co-cultured with OVA-specific T cells (5x10 4 , giving a DC: T cell ratio of 1:1). Notably, DCs were washed and medium renewed before co-culture with T cells to avoid direct stimulation from fatty acids on T cells. Responder OVA-specific DO11.10 T cells were isolated and purified from spleens using the CD4 + T cell isolation kit II (Miltenyi Biotec GmbH) according to the manufacturer's instructions. Isolated T cells were stained with CellTrace™ Violet (CellTrace™ Violet Cell Proliferation Kit, Molecular Probes/Invitrogen) in a final concentration of 5 μM, prior to addition to the CD11c + cell cultures. After 6 days of co-culture T cells were harvested for flow cytometry analysis of proliferation and phenotype.
Gas chromatography analysis of fatty acid content in dendritic cells
Cultured DCs were pooled to 4-8 Ã 10 6 cells and washed four times with PBS. After complete evaporation of PBS, 4 μg of an internal fatty acid standard, 17:0 in phospholipid form (Larodan AB, Malmö, Sweden), dissolved in dichloromethane was added to the samples. Total lipids were extracted with 5 ml 2:1 chloroform-methanol solution for 1 h. 2 ml milliQ-H 2 O were added and phases separated by centrifugation. The non-polar phase was transferred to a new tube before liquid evaporation. Fatty acids were methylated for 1 h at 75°C using 1 ml 10% acetyl chloride in methanol and 1 ml toluene. 1 ml milliQ-H 2 O and 5 ml petroleum ether were added. The non-polar phase was transferred to a new tube before liquid evaporation. 
Results
The supplemented fatty acids were taken up by the dendritic cells (Fig 2A) , reflecting low purity and pronounced autofluorescence of in vitro cultured cells. CD11c + cells were gated, based on higher fluorescence than to the FMO control (Fig 2A) and Increase of costimulatory molecules on DCs after culture with arachidonic acid or DHA
We investigated whether supplementation with fatty acids affected DC expression of MHC class II (IA d ) and costimulatory molecules, CD80, CD86 and CD40. As seen in Fig 3A, expression of MHC class II, i.e. IA d , was unaffected by fatty acids, only a non-significant reduction was observed with arachidonic acid. Supplementation with oleic acid or α-linolenic acid induced non-significantly higher CD80 expression ( Fig 3A) . In contrast, CD86 was significantly up-regulated on CD11c + CD11b neg DCs in response to arachidonic acid and DHA, and also tended to increase on CD11c + CD11b + cells in response to DHA (Fig 3A) . CD40 expression was up-regulated on CD11c + CD11b + in cultures with arachidonic acid or DHA, and on 
Generation of prostaglandin E 2 in arachidonic acid-primed dendritic cell cultures
We also measured soluble factors in the supernatant of DC cultures stimulated with the fatty acids arachidonic acid, DHA or oleic acid for 72 hours. We observed high levels of PGE 2 , >2 pg/ml, in DC cultures stimulated with arachidonic acid whereas <0.2 pg/ml of PGE 2 was found with the other stimuli ( Fig 5B) . Since we observed an upregulation of CD83 expression on DCs supplemented with arachidonic acid and DHA we also measured soluble CD83 (sCD83) in the supernatant. Only low levels of sCD83 was detected, and without differences between the groups (Fig 5A) . The levels of IL-10, IL-12 p70, and IFNγ were below detection limit while TGF-β1 levels were in pair with the levels in fresh complete IMDM (containing fetal bovine serum), with no differences between the groups.
In conclusion, MHC expression on DCs was unaffected by fatty acids, while arachidonic acid and DHA up-regulated the costimulatory molecules CD40, CD83, CD86 and the inhibitory molecule PDL-1. However, arachidonic acid distinguished itself from the other fatty acids in its ability to induce PGE 2 production.
Dendritic cells cultured with arachidonic acid or DHA reduced T-cell proliferation
Next, we investigated if the fatty acid exposure of DCs would alter the outcome of the antigenpresentation to naïve T cells. Therefore, DCs were cultured with fatty acid and the model antigen OVA for 3 days, thereafter OVA-specific DO11.10 + T cells were added to the DC cultures (S1 Fig) . The gating strategy of T cells is shown in Fig 6A and 6B . Briefly, lymphocytes were gated (upper 3 panels, Fig 6A) , followed by gating for DO11.10 expression (middle panel, Fig  6A) . Proliferation is shown in the lower panel of Fig 6A. After culture with OVA, about 25% of the T cells had divided, only 2% had divided in the absence of antigen. The solvent, ethanol had an inhibitory effect on proliferation, i.e. about 20% of the T cells proliferated in control cultures ( Fig 6A) . Arachidonic acid-or DHA-primed DCs reduced subsequent T-cell proliferation, compared to the control DCs, from % 20% to % 5% (Fig 6C) . Expression of the activation markers CD69 and CD25 was reduced in parallel (Fig 6D and 6E ). There was a correlation between proliferation and expression of CD69 (r = 0.8587, p < 0.0001) as well as proliferation and CD25 (r = 0.8935, p < 0.0001) (S4 Fig). None of the other investigated fatty acids (linoleic acid, α-linolenic acid, oleic acid or EPA) suppressed the capacity to activate T cells.
Cell death in T-cell cultures with arachidonic acid-or DHA-primed dendritic cells
We determined the levels of apoptosis and necrosis in the T cells by staining with Annexin V and 7AAD. The gating strategy is shown in Fig 7A and 7B . Briefly, to identify debris, live cells (Annexin V -7AAD -) were gated and on those cells we put a non-debris gate from which CD4 + T cells were gated for Annexin V and 7AAD staining. There was a non-significantly lower proportion of live T cells in the DC: T cell co-cultures with arachidonic acid-primed DCs compared to control cultures (70% vs 80%, Fig 7C) and a corresponding increase in late stage apoptotic/necrotic cells (Annexin V + 7AAD + , % 20% compared to 5%, Fig 7D) , but no differences in early stage apoptotic T cells (Annexin V + 7AAD -, Fig 7E) .
Regulatory T cells in cultures with arachidonic acid-or DHA-primed dendritic cells
Since arachidonic acid and DHA were the only fatty acids that affected DC phenotype as well as the DCs' ability to induce T-cell proliferation and activation markers, we chose to focus on these and included oleic acid as an inert fatty acid control. (Fig 9) . In summary, DCs supplemented with arachidonic acid and, to some extent, DHA inhibit T-cell proliferation, accompanied by a higher proportion of Tregs. These Tregs have a similar phenotype as Tregs found in oleic acid or control cultures. 
Lower levels of IL-10 and IFNγ with arachidonic acid-primed DCs in DC: T cell co-cultures
The DC: T cell co-culture supernatant from samples with arachidonic acid-primed DCs contained lower levels of IL-10 and IFNγ compared to control (Fig 10A and 10B) , which supports the low T-cell stimulatory activity with arachidonic acid. No reduction of cytokines was shown with DHA-primed DCs, compared to controls, which suggests less T-cell suppression (Fig 10A  and 10B ). IL-12 p70 was below limit of detection, TGF-β1 was in pair with the levels in fresh complete IMDM, with no differences between the groups, while sCD83 was found in higher levels than those found in DC culture supernatant, but still without differences between the groups (S7 Fig). The PD-1: PDL1 pathway is partly responsible for the low proliferation in DC: T cell co-cultures with arachidonic acid-or DHA-primed DCs DCs supplemented with arachidonic acid or DHA had increased expression of PDL-1 and CD83. To evaluate if these markers were involved in the reduced T-cell activation induced by such DCs we added either anti-CD83 or anti-PD-1 blocking antibodies to the DC: T-cell co- cultures. To achieve a more efficient blocking we blocked PD-1 instead of PDL-1, because PD-1 can also bind another molecule, PDL-2. As demonstrated in Fig 11 blocking of PD-1 led to increased proliferation in all DC: T-cell co-cultures. Blocking of PD-1 in arachidonic acid cultures did not restore proliferation to control levels, indicating that other pathways are involved in the low T-cell response. Blocking of CD83 led to lower proliferation in all DC: T-cell co-cultures. This supports the literature describing CD83 as an activation [35] and maturation marker [36] .
The PD-1: PDL-1 pathway promotes induction of Tregs [37] , so therefore we tested if PD-1 blocking changed the Treg phenotype or functionality. Indeed, the proportion of FoxP3 
Discussion
In the present study we tested the effect of six fatty acids on expression of MHC class II and costimulatory molecules on DCs and on the ability of the DCs to induce proliferation of naïve T cells in the presence of antigen. Culture of DCs with the long-chain PUFAs arachidonic acid or DHA, but no other fatty acid, led to increased expression of CD40, CD83 and CD86 as well as PDL-1 on the DC. Strikingly, however, DCs exposed to arachidonic acid or DHA induced lower antigen-specific T-cell proliferation and activation compared to DCs cultured in control medium. In parallel, a lower proportion of naïve T cells co-cultured with arachidonic acid-or DHA-primed DCs expressed the activation markers CD25 and CD69. Thus, despite a mature phenotype, DCs supplemented with the n-6 PUFA arachidonic acid or the n-3 PUFA DHA, did not activate T cells.
Tregs, that express the lineage-specific transcription factor FOXP3 are known to prevent effector T-cell proliferation [38] . Immunosuppressive effects of fatty acids mediated by induction of Tregs have been obtained by EPA supplementation during transplantation [39] and by dietary intake of arachidonic acid and DHA, together but not one by one, in a mouse model of dermatitis [40] . DC expression of the costimulatory molecules CD40, CD80 and CD86, has been inversely associated with generation of FoxP3 + T cells from naïve CD4 + T cells [41] but in our study the number of FoxP3 + Helios + DO11.10 + T cells were higher after supplementation with arachidonic acid or DHA to DCs, despite up-regulated activation markers. CTLA-4 is an inhibitory molecule important for Tregs, stored intracellular, but mobilized to the surface upon activation [42] where it binds CD80 or CD86. It has been reported as necessary for generation of Tregs in vitro [43] . In our study CTLA-4, measured intracellular, was not up-regulated in the T-cell cultures with suppressed proliferation. However our DC: T-cell co-culture lasted for 6 days, and Linsley et al. [44] have reported that surface expression of CTLA-4 peaks 48 h after activation and returns to normal levels after additionally 48 hours. Altogether, if the decreased T-cell proliferation was due to induction of Tregs, and the higher proportion of Tregs was not the result of limited T-cell proliferation, we have shown that arachidonic acid and DHA can induce FoxP3 + Helios + Tregs in vitro via DCs.
PD-1: PDL-1 interaction can inhibit T-cell proliferation and activation [23, 45] and could therefore be expected to be responsible for the T-cell unresponsiveness. Proposed mechanisms are induction of Tregs [37] . With arachidonic acid and DHA DCs had higher PDL-1 MFI than control DCs. However, the corresponding receptor PD-1 was not up-regulated on T cells. Our blocking experiment showed that PD-1 blocking decreased the proportion of FoxP3 + Helios + T cells, which negatively correlated with increased proliferation. This effect was not limited to any of the stimuli. The FoxP3 + Helios + subset is generally regarded as thymus derived so we question if these cells are generated in vitro or if they're decreased due to higher proliferation of effector T cells. If so, FoxP3 + Helios neg T cells has proliferated to the same extent as FoxP3 neg T cells, since PD-1 blocking did not change the proportion of these. Expression of PD-1 has also been associated with programmed cell death [46] . Therefore we analyzed T-cell viability with Annexin V and 7AAD. The level of apoptotic and necrotic cells was generally low, with reduced viability in cultures with arachidonic acid or DHA. This might be due to lack of proliferation, an induction of tolerance via cell death. CD83 was up-regulated with arachidonic acid and DHA. To our knowledge no association between fatty acids and CD83 has been reported. The most established role for CD83 is involvement in maturation of CD4 + T cells in the thymus [47] . In different setups CD83 has been shown to support expansion of newly primed naïve CD8 + T cells [48] , be required for lymphocyte longevity [35] , enhance DCs' stimulatory capacity [49] and thereby induce allogeneic T-cell proliferation [50] . However, the lack of a known ligand have hampered mechanistic explanations of CD83. CD83 expression has been correlated to expression of MHC class II [47, 51, 52] and CD86 [47, 52] . Here, up-regulation of CD83 correlated with up-regulation of CD86, and CD83 blocking resulted in decreased proliferation, suggesting a stimulatory role for CD83. CD83 is also found in soluble form, sCD83, formed via proteolytic cleavage of membrane-bound CD83 [53] . The extracellular soluble CD83 domain can inhibit DC-mediated T-cell proliferation [54] as well as inhibit T-cell proliferation and production of IL-2 and IFNγ in vitro [55, 56] . We measured sCD83 but found no differences between the groups, so this could not explain the T-cell unresponsiveness observed in cultures stimulated with arachidonic acid and DHA.
Rather than having an effect on cell membrane fluidity the effects of arachidonic acid and DHA can be caused by fatty-acid specific mechanisms. As free fatty acids, arachidonic acid and DHA are metabolically active compounds with ability to regulate intracellular signaling pathways and gene transcription but also serve as precursors for lipid mediators involved in inflammation. However, the suppressive effect of PUFAs can be independent of lipid mediators, as blocking of conversion enzymes in DCs not necessarily limit suppression of T-cell activation [25] . Because of the involvement in intracellular signaling the levels of free fatty acids are regulated on several levels. Most fatty acids are esterified and bound in the membrane or in triglycerides. Carrier proteins, such as fatty acid binding proteins (FABPs), can increase the solubility and regulate the accessibility of the fatty acids to their target molecules. PUFAs can affect expression for a plethora of genes, including the nuclear receptor peroxisome proliferator-activating receptors (PPARs) [57] . PPARγ is up-regulated in DCs upon differentiation [58] and its expression can be induced by DHA [32] . PPARγ induction reduces DC expression of CD40, CD80 and CD86 and capacity to activate naïve CD4 + T cells in vitro, as shown by decreased IL-2 and IFNγ production [59] .
Other studies have determined the lipid content of DCs and the association to antigen presenting capacity. However the results are contradictory, DCs with high lipid content, in comparison to DCs with low lipid content, have been shown to be both tolerogenic [60] but also pro-immunogenic [61] . In a study by Herber et al. MHC molecules, CD40, CD80, CD86 and DC-SIGN were unaffected by triglyceride content while in a study by Ibrahim et al. lipid-laden DCs had higher expression of CD1d, CD40, CD54, CD80 and CD86. Our DCs, stimulated with arachidonic acid or DHA, displayed an activated phenotype but yet seemed to act in a more tolerogenic fashion resulting in low T-cell responses. We did not measure total lipid content of our DCs but it might be that total fatty acid content is not the parameter that drives DCs to become more or less tolerogenic. Instead ratios between different fatty acids or content of individual fatty acids might be the immunomodulatory parameter. Arachidonic acid had a stronger suppressive capacity than DHA and lowered the levels of IL-10 and IFNγ, but gave higher DC culture supernatant levels of PGE 2 . Our result is in line with the notion that longchain PUFAs reduce T-cell proliferation, but we can show that this is true not only when the fatty acids are added to the T cells but also when supplemented to DCs in an earlier cell culture. The induction of FoxP3 + Tregs warrants further studies of the capability of these Tregs to suppress other T cells.
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